MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1

BACKGROUND: Anaplastic thyroid cancer (ATC) is considered to be a rare type of thyroid cancer but takes up the most important proportion of thyroid cancer-related deaths. Therefore, the development of molecular targeted therapy is an exciting strategy in the management of ATC. METHODS: miR-155 and S...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Ji, Wenyue, Zhao, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852915/
https://www.ncbi.nlm.nih.gov/pubmed/31718618
http://dx.doi.org/10.1186/s12885-019-6319-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852915/
https://www.ncbi.nlm.nih.gov/pubmed/31718618
http://dx.doi.org/10.1186/s12885-019-6319-4

Ejemplares similares